UPDATE: Credit Suisse Raises Price Target On Universal Health Services On 2015 EBITDA Estimate
In a report published Thursday, Credit Suisse analyst Ralph Giacobbe reiterated an Outperform rating on Universal Health Services, Inc. (NYSE: UHS), and raised the price target from $118.00 to $124.00.
In the report, Credit Suisse noted, “We are increasing our TP for UHS to $124 (from $118), which pegs a ~10.5x multiple on our 2015 EBITDA estimate. We maintain our Outperform rating on shares of UHS. Please see our 1/8/15 note, ‘Don't Sell 'Em Short as Year 2 of Reform Should Pack Healthy Punch' for more details.”
Universal Health Services closed on Wednesday at $111.99.
Latest Ratings for UHS
Date | Firm | Action | From | To |
---|---|---|---|---|
Mar 2022 | UBS | Maintains | Sell | |
Mar 2022 | Mizuho | Maintains | Buy | |
Feb 2022 | Seaport Global | Downgrades | Buy | Neutral |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Credit Suisse Ralph GiacobbeAnalyst Color Price Target Analyst Ratings